LOHR, Frank Reinhard Heinrich
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 30.312
AS - Asia 9.589
EU - Europa 7.997
SA - Sud America 1.634
Continente sconosciuto - Info sul continente non disponibili 727
AF - Africa 204
OC - Oceania 35
Totale 50.498
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 29.585
SG - Singapore 2.636
GB - Regno Unito 1.805
HK - Hong Kong 1.770
CN - Cina 1.761
IT - Italia 1.385
BR - Brasile 1.243
FI - Finlandia 1.110
SE - Svezia 1.071
VN - Vietnam 1.051
DE - Germania 886
BD - Bangladesh 795
TR - Turchia 568
RU - Federazione Russa 420
FR - Francia 296
CA - Canada 295
UA - Ucraina 255
BG - Bulgaria 233
IN - India 179
AR - Argentina 149
ID - Indonesia 136
BZ - Belize 122
KR - Corea 121
JP - Giappone 101
MX - Messico 98
NL - Olanda 90
IQ - Iraq 76
AE - Emirati Arabi Uniti 71
IE - Irlanda 66
ZA - Sudafrica 61
ES - Italia 59
CO - Colombia 54
EC - Ecuador 52
PL - Polonia 50
MY - Malesia 49
PK - Pakistan 48
AT - Austria 45
BE - Belgio 44
CL - Cile 42
VE - Venezuela 41
CR - Costa Rica 37
SA - Arabia Saudita 36
CZ - Repubblica Ceca 34
AU - Australia 26
HN - Honduras 26
MA - Marocco 25
LT - Lituania 24
PH - Filippine 24
EG - Egitto 23
PY - Paraguay 23
UZ - Uzbekistan 21
JM - Giamaica 20
NI - Nicaragua 19
JO - Giordania 18
DZ - Algeria 17
KE - Kenya 17
RO - Romania 17
TT - Trinidad e Tobago 17
CH - Svizzera 16
PR - Porto Rico 16
SV - El Salvador 16
DO - Repubblica Dominicana 15
PE - Perù 15
TN - Tunisia 15
GT - Guatemala 14
IL - Israele 14
TH - Thailandia 14
NP - Nepal 13
PT - Portogallo 13
AZ - Azerbaigian 12
TW - Taiwan 10
BY - Bielorussia 9
DK - Danimarca 9
KZ - Kazakistan 9
EE - Estonia 8
SI - Slovenia 8
BO - Bolivia 7
GR - Grecia 7
AL - Albania 6
BB - Barbados 6
BH - Bahrain 6
IR - Iran 6
NZ - Nuova Zelanda 6
QA - Qatar 6
RS - Serbia 6
SN - Senegal 6
XK - ???statistics.table.value.countryCode.XK??? 6
CW - ???statistics.table.value.countryCode.CW??? 5
GP - Guadalupe 5
HU - Ungheria 5
LB - Libano 5
NO - Norvegia 5
PA - Panama 5
SC - Seychelles 5
SY - Repubblica araba siriana 5
TG - Togo 5
AM - Armenia 4
CI - Costa d'Avorio 4
CY - Cipro 4
ET - Etiopia 4
Totale 49.698
Salva come PNG Salva come JPEG
Città #
Fairfield 3.531
Ashburn 3.485
Santa Clara 2.032
Singapore 1.890
Hong Kong 1.746
Houston 1.598
Woodbridge 1.546
Chandler 1.456
Seattle 1.395
Cambridge 1.177
San Jose 1.119
Wilmington 1.099
Helsinki 1.083
Southend 898
Council Bluffs 802
Dearborn 717
London 626
Nyköping 531
Ann Arbor 528
Izmir 376
Jacksonville 372
Beijing 349
Ho Chi Minh City 323
The Dalles 307
San Diego 303
Los Angeles 299
Princeton 251
New York 237
Buffalo 234
Hanoi 229
Sofia 222
Boardman 216
Modena 215
Chicago 200
Eugene 195
Milan 191
Lauterbourg 174
Dallas 147
Istanbul 146
Las Vegas 143
Hefei 136
São Paulo 133
Moscow 128
Bremen 127
Columbus 126
Belize City 122
Shanghai 114
Seoul 112
Albuquerque 104
Munich 102
Redondo Beach 99
Jakarta 88
Saint Augustine 87
Rome 86
Tokyo 81
Saint Louis 77
Frankfurt am Main 72
Atlanta 63
North Bergen 62
Salt Lake City 57
Dublin 55
Phoenix 55
Toronto 53
Orem 51
Brooklyn 47
Montreal 47
San Francisco 47
Falls Church 46
Warsaw 45
Denver 44
Miano 44
Naples 43
Boston 42
Haiphong 42
Dong Ket 41
Kunming 41
Da Nang 39
Brussels 38
Guangzhou 37
Washington 37
Nuremberg 35
Norwalk 34
Chennai 33
Raleigh 32
Bologna 30
Amsterdam 29
Baghdad 29
Brasília 29
Johannesburg 29
Mexico City 29
Nanjing 29
Tampa 29
Rio de Janeiro 28
Norfolk 27
Elk Grove Village 26
Miami 26
Paris 26
Chapel Hill 25
Charlotte 25
San José 25
Totale 35.833
Salva come PNG Salva come JPEG
Nome #
Deep Inspiration Breath Hold-Based Radiation Therapy: A Clinical Review 578
Simulation of 3D-treatment plans in head and neck tumors aided by matching of digitally reconstructed radiographs (DRR) and on-line distortion corrected simulator images 411
Pros-IT CNR: an Italian prostate cancer monitoring project 368
Sequential chemo-hypofractionated RT versus concurrent standard CRT for locally advanced NSCLC: GRADE recommendation by the Italian Association of Radiotherapy and Clinical Oncology (AIRO) 342
Optimized Volumetric Modulated Arc Therapy Versus 3D-CRT for Early Stage Mediastinal Hodgkin Lymphoma Without Axillary Involvement: A Comparison of Second Cancers and Heart Disease Risk 335
Assessment of neuropsychological changes in patients with arteriovenous malformation (AVM) after radiosurgery 331
Disease-specific and general health-related quality of life in newly diagnosed prostate cancer patients: The Pros-IT CNR study 316
Adjuvant IMRT/XELOX radiochemotherapy improves long-term overall- and disease-free survival in advanced gastric cancer 309
A comparison of several modulated radiotherapy techniques for head and neck cancer and dosimetric validation of VMAT 308
A new strategy for online adaptive prostate radiotherapy based on cone-beam CT 307
Expert system classifier for adaptive radiation therapy in prostate cancer 307
Adjuvant therapy in resectable gastric cancer—the CRITICS trial 304
Volumetric modulated arc therapy (VMAT) vs. serial tomotherapy, step-and-shoot IMRT and 3D-conformal RT for treatment of prostate cancer 303
A fast radiotherapy paradigm for anal cancer with volumetric modulated arc therapy (VMAT) 302
A machine learning tool for re-planning and adaptive RT: A multicenter cohort investigation 300
ACCURACY OF ULTRASOUND-BASED IMAGE GUIDANCE FOR DAILY POSITIONING OF THE UPPER ABDOMEN: AN ONLINE COMPARISON WITH CONE BEAM CT 296
A NOVEL DEVICE FOR INTRAVAGINAL ELECTRONIC BRACHYTHERAPY 294
Stereotactic Ablative Radiotherapy as an Alternative to Lobectomy in Patients With Medically Operable Stage I NSCLC: A Retrospective, Multicenter Analysis 294
Accelerating total body irradiation with large field modulated arc therapy in standard treatment rooms without additional equipment 290
Performance of an atlas-based autosegmentation software for delineation of target volumes for radiotherapy of breast and anorectal cancer 290
Phantom and in-vivo measurements of dose exposure by image-guided radiotherapy (IGRT): MV portal images vs. kV portal images vs. cone-beam CT 289
Efficacy of stereotactic body radiotherapy in oligorecurrent and in oligoprogressive prostate cancer: New evidence from a multicentric study 288
Hypofractionated image-guided breath-hold SABR (Stereotactic Ablative Body Radiotherapy) of liver metastases - clinical results 280
Accuracy of ultrasound-based (BAT) prostate-repositioning: A three-dimensional on-line fiducial-based assessment with cone-beam computed tomography 280
Acute central nervous system (CNS) toxicity of total body irradiation (TBI) measured using neuropsychological testing of attention functions 278
Flattening filter free beams from TrueBeam and Versa HD units: Evaluation of the parameters for quality assurance 277
Cognitive function in patients with cerebral arteriovenous malformations after radiosurgery: Prospective long-term follow-up 276
Migration patterns in pulsed-field electrophoresis of DNA restriction fragments from log-phase mammalian cells after irradiation and incubation for repair 273
A Real-World, Multicenter, Observational Retrospective Study of Durvalumab After Concomitant or Sequential Chemoradiation for Unresectable Stage III Non-Small Cell Lung Cancer 273
Intrafraction motion of the prostate during an IMRT session: a fiducial-based 3D measurement with Cone-beam CT 272
Stereotactic single-dose radiation therapy of liver tumors: Results of a phase I/II trial 271
Clinical outcome of hypofractionated breath-hold image-guided SABR of primary lung tumors and lung metastases 270
Fully automated, multi-criterial planning for Volumetric Modulated Arc Therapy – An international multi-center validation for prostate cancer 267
A novel lateral disequilibrium inclusive, (LDI) pencil-beam based dose calculation algorithm: Evaluation in inhomogeneous phantoms and comparison with Monte Carlo calculations 266
A multi-national report on stereotactic body radiotherapy for oligometastases: Patient selection and follow-up* 265
Predictive value of the flow cytometric PCNA assay (proliferating cell nuclear antigen) in head and neck tumors after accelerated-hyperfractionated radiochemotherapy 265
In-vivo treatment accuracy analysis of active motion-compensated liver SBRT through registration of plan dose to post-therapeutic MRI-morphologic alterations 264
Adding Concomitant Chemotherapy to Postoperative Radiotherapy in Oral Cavity Carcinoma with Minor Risk Factors: Systematic Review of the Literature and Meta-Analysis 263
Lethal pulmonary toxicity after autologous bone marrow transplantation peripheral blood stem cell transplantation for hematological malignancies 263
A multinational report of technical factors on stereotactic body radiotherapy for oligometastases 263
Dose-escalated salvage radiotherapy after radical prostatectomy in high risk prostate cancer patients without hormone therapy: outcome, prognostic factors and late toxicity 263
Quantification and Assessment of Interfraction Setup Errors Based on Cone Beam CT and Determination of Safety Margins for Radiotherapy 261
Reirradiation of Spinal Column Metastases Comparison of Several Treatment Techniques and Dosimetric Validation for the Use of VMAT 257
Adjuvant treatment of brain metastases 257
Differential sensitivity of three sublines of the rat dunning prostate tumor system R3327 to radiation and/or local tumor hyperthermia 256
Extracranial stereotactic radiation therapy: Set-up accuracy of patients treated for liver metastases 256
Fractionated stereotactic conformal radiation therapy of brain stem gliomas: outcome and prognostic factors 253
STEREOTACTIC, SINGLE-DOSE IRRADIATION OF LUNG TUMORS: A COMPARISON OF ABSOLUTE DOSE AND DOSE DISTRIBUTION BETWEEN PENCIL BEAM AND MONTE CARLO ALGORITHMS BASED ON ACTUAL PATIENT CT SCANS 253
OXYGEN-TENSION DISTRIBUTION IN HEAD AND NECK CARCINOMAS AFTER PERORAL OXYGEN-THERAPY 251
No evidence of oncogenic KRAS mutations in squamous cell carcinomas of the anogenital tract and head and neck region independent of human papillomavirus and p16 (INK4a) status 251
Radiotherapy for Early Mediastinal Hodgkin Lymphoma According to the German Hodgkin Study Group (GHSG): The Roles of Intensity-Modulated Radiotherapy and Involved-Node Radiotherapy 250
Cataract incidence after total-body irradiation 247
Assessment of focal liver reaction by multiphasic CT after stereotactic single-dose radiotherapy of liver tumors 247
Evaluation of a 2D detector array for patient-specific VMAT QA with different setups 245
Radiotherapy for tumors of the stomach and gastroesophageal junction - a review of its role in multimodal therapy 244
Comparison of intensity-modulated radiotherapy with conventional conformal radiotherapy for complex-shaped tumors 243
Enhancement of radiotherapy by hyperthermia-regulated gene therapy 243
Nivolumab in Combination with Stereotactic Body Radiotherapy in Pretreated Patients with Metastatic Renal Cell Carcinoma. Results of the Phase II NIVES Study 243
Arc therapy for total body irradiation - A robust novel treatment technique for standard treatment rooms 242
Neurobehavioral toxicity of total body irradiation: A follow-up in long-term survivors 242
Radiosurgery alone or in combination with whole-brain radiotherapy for brain metastases 242
Genital invasion or perigenital spread may pose a risk of marginal misses for Intensity Modulated Radiotherapy (IMRT) in anal cancer 242
"Freezing" the Tumor in a Known Position During Radiation Therapy In Regard to Boda-Heggemann et al 242
A novel surface imaging system for patient positioning and surveillance during radiotherapy A phantom study and clinical evaluation 241
Influence of Institutional Experience and Technological Advances on Outcome of Stereotactic Body Radiation Therapy for Oligometastatic Lung Disease 241
COMBINED ADJUVANT RADIOCHEMOTHERAPY WITH IMRT/XELOX IMPROVES OUTCOME WITH LOW RENAL TOXICITY IN GASTRIC CANCER 240
Flattening-filter-free intensity modulated breath-hold image-guided SABR (Stereotactic ABlative Radiotherapy) can be applied in a 15-min treatment slot 240
Fully automated treatment planning of spinal metastases - A comparison to manual planning of Volumetric Modulated Arc Therapy for conventionally fractionated irradiation 240
Prognostic Relevance of HPV Infection and p16 Overexpression in Squamous Cell Anal Cancer 239
Review of potential improvements using MRI in the radiotherapy workflow 239
Dose-dependent changes in renal H-1-/Na-23 MRI after adjuvant radiochemotherapy for gastric cancer 238
Long-term adjuvant administration of temozolomide in patients with glioblastoma multiforme: experience of a single institution 238
Frameless stereotactic radiosurgery of a solitary liver metastasis using active breathing control and stereotactic ultrasound 237
Development of a neuro-fuzzy technique for automated parameter optimization of inverse treatment planning 237
Image-guided radiation therapy 236
Improving dose homogeneity in large breasts by IMRT - Efficacy and dosimetric accuracy of different techniques 235
Comparison of anisotropic aperture based intensity modulated radiotherapy with 3D-conformal radiotherapy for the treatment of large lung tumors 235
Patient-specific online dose verification based on transmission detector measurements 234
Development of a Geant4 based Monte Carlo Algorithm to evaluate the MONACO VMAT treatment accuracy 234
Management of small bowel interferences in primary radiotherapy of prostate cancer 233
Direct dose correlation of MRI morphologic alterations of healthy liver tissue after robotic liver SBRT 233
X-ray induced changes in immunostaining of proliferating cell nuclear antigen (PCNA) in V79 hamster fibroblasts 232
On the performances of different IMRT treatment planning systems for selected paediatric cases 231
Assessment of renal function after conformal radiotherapy and intensity-modulated radiotherapy by functional H-1-MRI and (23) Na-MRI 230
SIS epidemiological model for adaptive RT: Forecasting the parotid glands shrinkage during tomotherapy treatment 230
Dosimetric consequences of a translational isocenter correction based on image guidance for intensity modulated radiotherapy (IMRT) of the prostate 230
Robustness of sweeping-window arc therapy treatment sequences against intrafractional tumor motion 230
Fast kilovoltage/megavoltage (kVMV) breathhold cone-beam CT for image-guided radiotherapy of lung cancer 228
A systematic review and meta-analysis on oncological radiotherapy in patients with a cardiac implantable electronic device: Prevalence and predictors of device malfunction in 3121 patients 227
Experimental validation of a commercial 3D dose verification system for intensity-modulated arc therapies 227
Conformal radiotherapy of challenging paraspinal tumors using a multiple arc segment technique 227
Optimization of dose distributions for adjuvant loco-regional radiotherapy of gastric cancer by IMRT 227
Critical appraisal of the role of volumetric modulated arc therapy in the radiation therapy management of breast cancer 227
Intra-breath-hold residual motion of image-guided DIBH liver-SBRT: An estimation by ultrasound-based monitoring correlated with diaphragm position in CBCT 227
Treatment paths for localised prostate cancer in Italy: The results of a multidisciplinary, observational, prospective study (Pros-IT CNR) 226
Fiducial-based quantification of prostate tilt using cone beam computer tomography (CBCT) 225
Should patients with locally advanced, non-metastatic carcinoma of the pancreas be irradiated? 225
Impact of gastrointestinal side effects on patients’ reported quality of life trajectories after radiotherapy for prostate cancer: Data from the prospective, observational pros-it CNR study 225
Cosmetic Results and Side Effects of Accelerated Partial-Breast Irradiation Versus Whole-Breast Irradiation for Low-Risk Invasive Carcinoma of the Breast: The Randomized Phase III IRMA Trial 224
Conventionally fractionated stereotactic radiotherapy (FSRT) for acoustic neuromas 224
Totale 26.350
Salva come PNG Salva come JPEG
Categoria #
all - tutte 212.670
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 212.670
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20223.040 0 0 0 0 168 149 265 292 409 371 837 549
2022/20233.998 544 697 368 237 584 431 74 339 441 31 168 84
2023/20242.029 87 137 86 223 416 134 125 388 54 26 67 286
2024/20256.758 278 58 29 394 1.490 1.088 369 349 743 547 585 828
2025/202613.155 531 323 1.217 1.320 1.085 1.164 1.881 858 1.167 1.039 1.353 1.217
2026/20274.684 601 919 1.098 1.976 90 0 0 0 0 0 0 0
Totale 50.498